| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |